Imaging Physics for the Orthopaedic Surgeon
- Justify, then minimise: about 50 mGy to red marrow roughly tripled the relative risk of leukaemia, but the absolute excess was about one leukaemia and one brain tumour per 10,000 head CTs in a child under 10; a justified scan is done, with the dose kept as low as possible.
- In pregnancy an abdominal lead shield can raise the dose during CT, because it enters the automatic-exposure-control field; shorten the scan instead.
- CT protocols vary widely and are often incomplete (17 hip arthroplasty planning protocols, kV 100-150, mAs 100-250); a harmonised low-dose protocol optimised for field of view and acquisition parameters is needed.
- Scan length costs nothing to get right, and trimming it is the cheapest dose reduction available.
- βWater 0 HU, air -1000, fat ~-100, soft tissue +30-60, dense bone ~+1000. Window level = central HU, width = range displayed; a fracture is seen best on a bone window.
- βCTDIvol (mGy) = dose intensity in a phantom, independent of length; DLP (mGy.cm) = CTDIvol x scan length; effective dose (mSv) = DLP x region-specific k-factor.
- βDose is directly proportional to mAs, rises faster than in proportion with kVp, and falls as pitch rises at a fixed tube current.
- βStandard CT pulmonary angiogram fetal dose ~0.1 mGy; the shield raised maternal effective dose by 47% and did not lower fetal dose; shortening the scan cut fetal dose by 70%.
How CT Works & the Hounsfield Scale
Forming the image. A CT scanner rotates an X-ray tube and opposing detectors around the patient and measures X-ray attenuation from many angles. A computer reconstructs those profiles, by filtered back-projection or iterative reconstruction, into cross-sectional images of tissue attenuation. Modern helical multidetector CT acquires large volumes rapidly and allows multiplanar and 3D reconstruction, the basis of orthopaedic 3D planning.
The Hounsfield scale. Each voxel is assigned a Hounsfield unit, or CT number: its attenuation normalised to a scale on which water is 0 HU and air is -1000 HU. Know where water, air and bone sit and the rest of the scale can be interpreted from them.
- Approximate Hounsfield units
- -1000 HU
- Approximate Hounsfield units
- around -100 HU
- Approximate Hounsfield units
- 0 HU (reference)
- Approximate Hounsfield units
- +30 to +60 HU
- Approximate Hounsfield units
- +50 to +90 HU
- Approximate Hounsfield units
- around +1000 HU, and higher
- Approximate Hounsfield units
- about +3000 HU - it saturates the scale (its streak artefact is explained below)


Windowing. The full Hounsfield range cannot be displayed at once, so a chosen range is mapped to the grey scale. The window level sets the central HU and the window width the range spread across the grey scale. A narrow soft-tissue window and a wide bone window therefore display different tissues from the same data, which is why a fracture is seen best on a bone window.


Parameters, Dose & ALARA
The acquisition parameters. kVp, the tube voltage, sets the beam energy and penetration. mAs, tube current multiplied by time, sets the number of photons and so the image noise. Pitch (table travel per rotation), slice thickness and field of view govern coverage, resolution and noise, and every one of these settings trades image quality against radiation dose.
Measuring the dose. Three metrics, each built on the one before:
- CTDIvol (mGy) is the average dose within the scanned volume, measured in a standard phantom (16 cm head, 32 cm body). It reflects dose intensity per rotation, is independent of scan length, and is a scanner-output index rather than the patient's true dose.
- DLP (mGyΒ·cm), the dose-length product, is CTDIvol Γ scan length, the total energy imparted over the whole scan.
- Effective dose (mSv) is DLP Γ a region-specific conversion factor (k). It weights for tissue radiosensitivity, so that stochastic (cancer) risk can be compared across body regions and modalities.
The magnitudes. A chest radiograph is around 0.02 mSv, a head CT about 2 mSv and an abdomen/pelvis CT roughly 5-10 mSv, against natural background radiation of about 2-3 mSv per year. An abdominopelvic CT is therefore equivalent to several years of background, the concrete basis for justification and ALARA.
Which way each parameter moves the dose. Change one setting and the dose moves predictably:
- mAs. Dose is directly proportional, so halving the tube current-time product halves the dose and raises the noise.
- kVp. Dose rises steeply and faster than in proportion, because kVp increases both the number and the energy of the photons. Lowering kVp in a small patient or a child saves a disproportionate amount.
- Pitch. At a fixed tube current, increasing pitch spreads the same output over more table travel and reduces dose (and z-axis resolution). Many scanners hold quality constant by automatically raising mAs as pitch rises, so pitch must always be read alongside the displayed CTDIvol rather than on its own.
- Slice thickness. Thinner slices improve resolution but need more photons per slice to hold noise constant, so they cost dose.
- Scan length. The parameter that costs nothing to get right: DLP grows with every centimetre covered, so trimming the coverage is the cheapest dose reduction available.
ALARA. CT delivers substantially more dose than plain radiography. The ALARA principle (As Low As Reasonably Achievable) requires the lowest dose that still answers the clinical question, supported by automatic exposure control, iterative reconstruction, appropriate kVp selection and a field of view limited to the region of interest. It matters most in young patients and women of childbearing age, in whom the lifetime risk of radiation-induced malignancy is greater.
Harmonised protocols. CT protocols vary widely and are often incomplete, which leads to inconsistency and unnecessary dose. Total hip arthroplasty planning shows it: across 17 published protocols the recommended kV (100-150) and mAs (100-250) varied widely, and most protocols were incomplete. What is needed is a harmonised low-dose protocol, optimised for both the field of view and the acquisition parameters, that balances diagnostic quality against patient dose.
CT Artefacts and How Dose Is Reduced
The artefacts. Metal is the orthopaedic problem, but it is one of five:
- Beam hardening. The polychromatic beam loses its low-energy photons passing through tissue, producing cupping and dark streaks between dense structures.
- Metal/streak. Dense implants cause beam hardening, photon starvation and scatter, and the bright and dark streaks obscure peri-prosthetic bone.
- Partial volume. A voxel spanning two tissues is averaged, which misleads at boundaries and is worse with thick slices.
- Motion. Blur and ghosting.
- Ring. A faulty detector element.
Reducing dose and artefact. Four techniques lower the dose, the artefact or both:
- Iterative (and deep-learning) reconstruction models the acquisition physics and statistics to give lower noise at a given dose, allowing roughly a third-to-half dose reduction compared with filtered back-projection.
- Automatic tube-current modulation varies mAs with patient attenuation, so dose is delivered only where it is needed.
- Lower kVp suits smaller patients and iodine-based angiography.
- Dual-energy CT enables material decomposition and high-keV monoenergetic and metal-artefact-reduction reconstructions that specifically reduce the orthopaedic metal artefact.


How Big Is the Risk, Actually - and What Shielding Does Not Do
"Protect the young" is not an answer on its own; put a number on it. In a retrospective cohort of around 178,000 patients first scanned before the age of 22 in Great Britain between 1985 and 2002, the dose-response was real. A cumulative red-marrow dose of about 50 mGy carried a relative risk of leukaemia of 3.18 against those receiving under 5 mGy, and about 60 mGy to the brain a relative risk of brain tumour of 2.82.
Leukaemia and brain tumours are rare, so the absolute excess was approximately one extra leukaemia and one extra brain tumour per 10,000 head CTs in the ten years after a first scan in a child under 10. That is the number to quote, and the authors' own conclusion follows from it: the clinical benefit of a justified scan outweighs the small absolute risk. Justify the scan, then minimise the dose; withholding CT from children is not the answer.
Note what was measured: absorbed dose to the specific organ in mGy, not effective dose in mSv. The cohort is retrospective, and the earliest scans delivered doses higher than a modern low-dose protocol would.

Lead shielding can raise the dose. In a phantom study of CT pulmonary angiography in pregnancy, abdominal shielding increased the mother's effective dose by 47% and raised the mean fetal absorbed dose from 0.10 to 0.12 mGy instead of reducing it. The shield sits within the field seen by automatic exposure control, which responds by driving the tube current up. Shortening the scan to the anatomy actually needed cut fetal dose by 70%, from 0.10 to 0.03 mGy.


The fetal dose in proportion. The fetal dose measured from a standard CT pulmonary angiogram was around 0.1 mGy, three orders of magnitude below the 50 to 60 mGy organ doses associated with the tripled childhood cancer risks above. A CT of a limb or shoulder in a pregnant patient is further still from the uterus. The judgement is about justification and scan length; refusing an indicated scan is not the answer.
Fluoroscopy is a different problem. The shielding finding applies to CT with automatic exposure control, where a lead blanket inside the scanned field misleads the scanner into raising output. It does not transfer to fluoroscopy in theatre, where the operator and staff stand in scattered radiation and personal lead remains the mainstay. Occupational protection, dose limits and the pregnant-staff pathway are covered under radiation safety in orthopaedics.
The clinical indications for CT, its orthopaedic applications and a fuller treatment of pitch and reconstruction sit in CT imaging principles, and the metal-artefact problem specifically in MRI metal artefact reduction.
Mnemonics & Memory Aids
SCAN
Hook:SCAN: Scale (Hounsfield/windowing), Current (mAs)/kVp, Acquisition (pitch/slice), No more dose than needed (ALARA).
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
βWhat is a Hounsfield unit, and how do the main CT parameters affect image quality and dose?β
Image formation
- Rotating X-ray tube + detectors measure attenuation from many angles
- Reconstruction (filtered back-projection/iterative) β cross-sectional image
- Helical multidetector CT β rapid volume, multiplanar/3D reconstruction
Hounsfield scale & windowing
- Water = 0 HU, air = -1000 HU, fat ~-100, soft tissue +30-60, bone ~+1000+
- Windowing: level = central HU, width = range across grey scale
- Bone window vs soft-tissue window (fracture best on bone window)
Parameters & dose
- kVp (energy), mAs (photon number/noise), pitch, slice thickness
- More dose β less noise/better resolution but higher dose
- Metrics: CTDIvol (mGy), DLP (mGy.cm), effective dose (mSv)
Safety
- ALARA; automatic exposure control; iterative reconstruction; low-dose protocols
- Paediatric risk with a number: ~50 mGy marrow RR 3.18 leukaemia, ~60 mGy brain RR 2.82 - but ~1 excess of each per 10,000 head CTs under age 10
- Pregnancy: fetal dose from a chest CT ~0.1 mGy; an abdominal shield RAISED maternal dose 47% via AEC - shorten the scan instead (-70%)
- Harmonise protocols (optimise field of view + parameters); trimming scan length is the cheapest dose cut
Evidence & Key Studies
Variability of CT protocols (for THA): a call for harmonisation and low dose
- CT is the principal modality for 3D planning/assessment in total hip arthroplasty, but its image quality carries a radiation penalty, of particular concern in young patients and women of childbearing age due to the greater risk of radiation-induced cancer.
- Across 17 protocols, recommended kV (100-150) and mAs (100-250) varied widely and most protocols were incomplete; CT parameters (kV, mAs, slice thickness) must be optimised with a field of view that includes the relevant bony landmarks.
- A harmonised low-dose CT protocol is needed that provides an optimal balance between image quality and radiation dose.
Dose-monitoring software alerts and CT radiation-dose reduction
- Radiation dose-monitoring software identifies high-dose CT examinations and alerts users, helping to reduce the number of high-dose events and optimise dose.
- High-dose alerts were triggered by patient and technical factors - overweight patients, scan repetition, miscentering, extra studies, orthopaedic hardware in the scan area, and scanning beyond the desired anatomy.
- Most studies showed dose-monitoring tools reduced high-dose events, supporting their role (with proper monitoring and staff training) in CT dose optimisation.
Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study
- Retrospective cohort of patients first examined by CT in NHS centres in Great Britain between 1985 and 2002 while under 22 years old: 74 leukaemias among 178,604 patients and 135 brain tumours among 176,587, with follow-up starting 2 years (leukaemia) and 5 years (brain tumour) after the first scan to exclude scans done for the cancer itself.
- Dose-response was significant for both: excess relative risk per mGy 0.036 for leukaemia and 0.023 for brain tumour. Against a dose under 5 mGy, a cumulative red-marrow dose of about 50 mGy gave a relative risk of leukaemia of 3.18 (95% CI 1.46-6.94) and about 60 mGy to the brain a relative risk of brain tumour of 2.82 (1.33-6.03).
- Because these cancers are rare the absolute risk is small - an estimated one excess leukaemia and one excess brain tumour per 10,000 head CTs in the 10 years after a first scan in a child under 10 - and the authors conclude that clinical benefit should outweigh it, provided dose is kept as low as possible and non-ionising alternatives are considered.
- Read the exposure categories rather than their midpoints: the leukaemia relative risk of 3.18 belongs to a cumulative dose of AT LEAST 30 mGy, whose mean happened to be 51 mGy, and the brain-tumour relative risk of 2.82 to the 50 to 74 mGy band, mean 60 mGy - so the commonly quoted round figures of 50 and 60 mGy are category means, not thresholds.
To use or not use patient shielding on pregnant women undergoing CT pulmonary angiography: a phantom study
- Fetal absorbed dose was measured with thermoluminescent dosemeters in a phantom undergoing CT pulmonary angiography, with maternal effective dose estimated from the dose-length product.
- Abdominal shielding increased the mother's effective dose by 47 percent and increased mean fetal absorbed dose from 0.10 to 0.12 mGy, because the shield entered the field used by automatic exposure control and drove the tube current up.
- Shortening the scan was the effective measure, cutting fetal absorbed dose by 70 percent from 0.10 to 0.03 mGy provided the necessary anatomical coverage was preserved. This is a phantom study, not a patient cohort, and applies to CT with automatic exposure control rather than to fluoroscopic shielding practice.
The radiation penalty of CT image quality (with particular concern for young patients/women of childbearing age), the wide variability of CT protocols and the need for a harmonised low-dose protocol that balances quality against dose come from the cited Ramesh review; the role of dose-monitoring software and the technical/patient factors that drive high-dose events (including orthopaedic hardware and miscentering) from the cited Alanazi review. The paediatric relative and absolute cancer risks come from the Pearce cohort, and the shielding and scan-length findings in pregnancy from the Begano phantom study. The CT image-formation physics, the Hounsfield scale (water 0, air -1000), windowing, the acquisition parameters (kVp/mAs/pitch/slice) and the dose metrics (CTDIvol/DLP/effective dose) with ALARA are standard, well-established teaching, as is the direction in which each parameter moves dose; no single trial establishes an exponent for the kVp-dose relationship, so none is quoted here. Nor is there a validated diagnostic reference level specific to orthopaedic CT that would let a target CTDIvol be given for a given examination.